Brian Bedell Maintained (CBOE) at Hold with Decreased Target to $60 on, Mar 6th, 2015

Show Health and Fitness Publications

Mon, November 14, 2016

[ Mon, Nov 14th 2016 ]: Market Wire

New Analyses of Phase 3 Trials Show Improvements .. oms Following Treatment with Baricitinib Across D

[ Mon, Nov 14th 2016 ]: Market Wire

Baricitinib Demonstrates Early Response Compared .. provement Compared to Adalimumab in Patient-Repor

Sun, November 13, 2016

[ Sun, Nov 13th 2016 ]: Market Wire

Jardiance (empagliflozin) consistently reduced th .. h in adults with type 2 diabetes regardless of th

Wed, November 9, 2016

[ Wed, Nov 09th 2016 ]: Market Wire

COLUMBUS Phase 3 Study Results in BRAF-Mutant Mel .. at Society for Melanoma Research Annual Congress

Thu, November 3, 2016

[ Thu, Nov 03rd 2016 ]: Market Wire

Lilly Presents Clinical Efficacy, Safety and Pati .. Baricitinib in Patients with Rheumatoid Arthriti

Wed, November 2, 2016

[ Wed, Nov 02nd 2016 ]: Market Wire

New data from pivotal RA-BEACON study show signif .. reported outcomes in rheumatoid arthritis patient

Mon, October 17, 2016

[ Mon, Oct 17th 2016 ]: Market Wire

Lilly Partners with the National Cancer Institute .. h through New Program under Cancer Moonshot Initi

Sat, October 8, 2016

[ Sat, Oct 08th 2016 ]: Market Wire

New Data on the Combination of Lilly's ALIMTA (pe .. A (pembrolizumab) Show a Near-Doubling of Objecti

Thu, October 6, 2016

[ Thu, Oct 06th 2016 ]: Market Wire

Research Reports Initiation on Healthcare Stocks -- NuVasive, Nevro, Spectranetics, and NovoCure

[ Thu, Oct 06th 2016 ]: Market Wire

Technical Roundup on Drug Makers Stocks -- Tonix .. rma, Retrophin, Heron Therapeutics, and GW Pharma

Wed, October 5, 2016

[ Wed, Oct 05th 2016 ]: Market Wire

Research Reports Coverage on Generic Drugs Stocks .. ernus Pharma, Lipocine, and Carbylan Therapeutics

[ Wed, Oct 05th 2016 ]: Market Wire

Biotech Stocks Technical Reports -- Peregrine Pha .. rapeutics, Aratana Therapeutics, and Vanda Pharma

[ Wed, Oct 05th 2016 ]: Market Wire

Lilly Highlights Advancements in its Oncology Portfolio with New Data at ESMO 2016

Mon, October 3, 2016

[ Mon, Oct 03rd 2016 ]: Market Wire

Biotechs with Key Corporate Developments

Fri, September 30, 2016

[ Fri, Sep 30th 2016 ]: Market Wire

Biotechs and the Advancements in Cancer Oriented Clinical Trials

[ Fri, Sep 30th 2016 ]: Market Wire

The Medical Device Industry's Focus on Cardio and Cardiovascular Needs

Thu, September 29, 2016

[ Thu, Sep 29th 2016 ]: Market Wire

Awareness Continues to Grow for Medical Uses of Cannabis

Tue, September 27, 2016

[ Tue, Sep 27th 2016 ]: Market Wire

Fighting Addiction and Other Unmet Medical Needs with Cannabidiol

[ Tue, Sep 27th 2016 ]: Market Wire

Multi-Billion Dollar Cannabis Operations Boosting .. ewest Cultivation Uses of Liquid Fulvic and Humic

[ Tue, Sep 27th 2016 ]: Market Wire

ProNAi Licenses Oncology Drug Targeting DNA Damag .. ckpoint Kinase 1 (Chk1) From CRT Pioneer Fund, UK

Mon, September 26, 2016

[ Mon, Sep 26th 2016 ]: Market Wire

The Week Many Have Been Waiting For

[ Mon, Sep 26th 2016 ]: Market Wire

The Bioscience and Biotechnology Sector Developments in Cancer Therapy

Fri, September 23, 2016

[ Fri, Sep 23rd 2016 ]: Market Wire

Shire to Showcase Continued Innovation and Leader .. uring European Society for Immunodeficiencies Bie

Thu, September 22, 2016

[ Thu, Sep 22nd 2016 ]: Market Wire

Biotechnology Companies Reaching New Milestones

[ Thu, Sep 22nd 2016 ]: Market Wire

Research Reports Coverage on Select Healthcare St .. obus Medical, Align Technology, and Nxstage Medic

[ Thu, Sep 22nd 2016 ]: Market Wire

Biotech Stocks on Investors' Radar -- Portola Pha .. bluebird bio, Auris Medical, and Cerulean Pharma

Wed, September 21, 2016

[ Wed, Sep 21st 2016 ]: Market Wire

Research Reports Coverage on Healthcare Stocks -- Aetna, Anthem, Humana, and BioScrip

Tue, September 20, 2016

[ Tue, Sep 20th 2016 ]: Market Wire

Advancing Preclinical Autoimmune Studies & Accele .. FDA Approvals Producing Rewards in Biotech Sector

[ Tue, Sep 20th 2016 ]: Market Wire

Generic Drugs Stocks on Investors' Radar -- Zoeti .. ris Bio, Rigel Pharma, and Neurocrine Biosciences

[ Tue, Sep 20th 2016 ]: Market Wire

Research Reports Initiation on Biotech Stocks -- .. ktar Therapeutics, GlobeImmune and Anthera Pharma

Mon, September 19, 2016

[ Mon, Sep 19th 2016 ]: Market Wire

Research Reports Initiation on Biotech Stocks -- .. apeutix, Infinity Pharma, Lpath, and Idera Pharma

[ Mon, Sep 19th 2016 ]: Market Wire

Research Reports Initiation on Specialized Health .. hcare Services, Healthways, MEDNAX, and HEALTHSOU

Sun, September 18, 2016

[ Sun, Sep 18th 2016 ]: Market Wire

Health Care Stocks on Investors' Radar -- Centene .. gna, Molina Healthcare, and WellCare Health Plans

Fri, September 16, 2016

[ Fri, Sep 16th 2016 ]: Market Wire

Technical Roundup on Healthcare Stocks -- ResMed, MiMedx, Varian Medical Systems, and Accuray

[ Fri, Sep 16th 2016 ]: Market Wire

Research Reports on Biotech Equities -- Galena Biopharma, Mast Therapeutics, Medivation, and Amgen

[ Fri, Sep 16th 2016 ]: Market Wire

CHMP Recommends Approval of Lilly's Olaratumab, i .. ith Doxorubicin, for Advanced Soft Tissue Sarcoma

Thu, September 15, 2016

[ Thu, Sep 15th 2016 ]: Market Wire

Boston Mayor Walsh and the Alzheimer's Associatio .. hire Chapter, Receive Alzheimer's Readiness Award

[ Thu, Sep 15th 2016 ]: Market Wire

Drug Makers Stocks Technical Reports -- Pernix Th .. rgy Pharma, Novo Nordisk, and Apricus Biosciences

Wed, September 14, 2016

[ Wed, Sep 14th 2016 ]: Market Wire

Research Reports Initiation on Healthcare Stocks .. , AmSurg, Quintiles Transnational, and Acadia Hea

[ Wed, Sep 14th 2016 ]: Market Wire

Shire Announces U.S. FDA Approval of CUVITRU[TM] .. (Human), 20% Solution] Treatment for Primary Imm

Mon, September 12, 2016

[ Mon, Sep 12th 2016 ]: Market Wire

Healthcare Stocks Technical Reports -- EnteroMedics, Neovasc, Amedica, and InspireMD

Fri, September 9, 2016

[ Fri, Sep 09th 2016 ]: Market Wire

Research Reports Coverage on Healthcare Stocks -- .. rma, Sanofi, Shire, and Universal Health Services

Thu, May 9, 2013

[ Thu, May 09th 2013 ]: Market Wire

Sunshine Heart, Inc. Announces First Patient Impl .. nted in C-Pulse System European Post-Market Study

[ Thu, May 09th 2013 ]: Market Wire

Trevena, Inc. and Forest Laboratories Announce a .. evelopment of TRV027 for the Treatment of Acute H

Wed, May 8, 2013

[ Wed, May 08th 2013 ]: Market Wire

Vorteile der Mammografie-Technologie zur Brust-To .. ner verffentlichten italienischen Studie besttigt

[ Wed, May 08th 2013 ]: Market Wire

I benefici della tecnologia Hologic per l'utilizz .. o corroborati dalla pubblicazione di uno studio i

Tue, May 7, 2013

[ Tue, May 07th 2013 ]: Market Wire

Luminex Corporation To Present At Upcoming Investment Conferences

[ Tue, May 07th 2013 ]: Market Wire

Gatorz Inc. Issues Stock Options and Mails Meeting Materials

Brian Bedell Maintained (CBOE) at Hold with Decreased Target to $60 on, Mar 6th, 2015

//stocks-investing.news-articles.net/content/201 .. with-decreased-target-to-60-on-mar-6th-2015.html

Published in Stocks and Investing on Friday, October 25th 2024 at 7:56 GMT by WOPRAI
^{🞛 This publication is a summary or evaluation of another publication}

Brian Bedell of Deutsche Bank, Maintained "Cboe Global Markets, Inc." (CBOE) at Hold with Decreased Target from $64 to $60 on, Mar 6th, 2015.

Brian has made no other calls on CBOE in the last 4 months.

There are 5 other peers that have a rating on CBOE. Out of the 5 peers that are also analyzing CBOE, 3 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months

Jeremy Campbell of "Barclays" Maintained at Hold with Decreased Target to $53 on, Tuesday, March 3rd, 2015
Michael Carrier of "B of A Securities" Downgraded from Strong Buy to Hold on, Friday, February 27th, 2015
Alex Kramm of "UBS" Downgraded from Strong Buy to Hold and Decreased Target to $62 on, Monday, February 9th, 2015

These are the ratings of the 2 analyists that currently disagree with Brian

Alexander Blostein of "Goldman Sachs" Downgraded from Hold to Strong Sell and Decreased Target to $56 on, Tuesday, January 13th, 2015
Ben Herbert of "Citigroup" Downgraded from Hold to Strong Sell on, Wednesday, December 3rd, 2014

Similar Health and Fitness Publications

[ Tue, Mar 03rd 2015 ]: WOPRAI
Category: Stocks and Investing

Jeremy Campbell Maintained (CBOE) at Hold with Decreased Target to $53 on, Mar 3rd, 2015

[ Fri, Feb 27th 2015 ]: WOPRAI
Category: Stocks and Investing

Michael Carrier Downgraded (CBOE) to Hold on, Feb 27th, 2015

[ Mon, Feb 09th 2015 ]: WOPRAI
Category: Stocks and Investing

Brian Bedell Maintained (CBOE) at Hold with Decreased Target to $64 on, Feb 9th, 2015

[ Mon, Feb 09th 2015 ]: WOPRAI
Category: Stocks and Investing

Alex Kramm Downgraded (CBOE) to Hold and Decreased Target to $62 on, Feb 9th, 2015

[ Mon, Feb 02nd 2015 ]: WOPRAI
Category: Stocks and Investing

Brian Bedell Maintained (BEN) at Hold with Decreased Target to $55 on, Feb 2nd, 2015

[ Fri, Jan 16th 2015 ]: WOPRAI
Category: Stocks and Investing

Kenneth Worthington Downgraded (TROW) to Sell and Decreased Target to $78 on, Jan 16th, 2015

[ Wed, Jan 14th 2015 ]: WOPRAI
Category: Stocks and Investing

Alexander Blostein Downgraded (BEN) to Hold on, Jan 14th, 2015

[ Fri, Dec 12th 2014 ]: WOPRAI
Category: Stocks and Investing

Brian Bedell Maintained (CBOE) at Hold with Increased Target to $66 on, Dec 12th, 2014

[ Wed, Dec 03rd 2014 ]: WOPRAI
Category: Stocks and Investing

Ben Herbert Downgraded (CBOE) to Strong Sell on, Dec 3rd, 2014

[ Fri, Mar 28th 2014 ]: WOPRAI
Category: Stocks and Investing

Murali Gopal Downgraded (C) to Hold on, Mar 28th, 2014

[ Thu, Mar 27th 2014 ]: WOPRAI
Category: Stocks and Investing

Brian Kleinhanzl Downgraded (C) to Hold and Decreased Target to $52 on, Mar 27th, 2014

[ Tue, Mar 18th 2014 ]: WOPRAI
Category: Stocks and Investing

Ken Usdin Maintained (C) at Hold with Decreased Target to $56 on, Mar 18th, 2014